Alzheimer Society of Canada’s Dr. Luca Pisterzi appointed to Canada’s Ministerial Advisory Board on dementia

Dr. Luca Pisterzi

The Alzheimer Society of Canada is pleased to announce that Dr. Luca Pisterzi, our Vice President of Research, Programs and Evidence has been appointed as a member of Canada’s Ministerial Advisory Board on Dementia. This designation highlights the importance of dementia research and the need for expert insights in shaping health policies for those impacted by Alzheimer’s and dementia, their families, and caregivers.
 
In his role on the advisory board, Dr. Pisterzi will consult with members to provide recommendations and insights on matters related to the health and well-being of people living with dementia.
 
Dr. Pisterzi is a respected researcher in the field of dementia, holding a PhD in Molecular Pharmacology and Biophysics and having committed over a decade of study to the complexities of the molecular underpinnings of Alzheimer’s disease and other dementias. Dr. Pisterzi’s expertise includes innovative approaches to dementia care and translating research findings into practical applications that enhance the quality of life for those affected. He is increasingly interested in developing supportive infrastructure to help add efficiency to research, accelerating our approach to a future without dementia.
 
“We are grateful to Canada’s Minister of Health, the Honourable Mark Holland, for this designation,” said Ray Bisson, the Alzheimer Society of Canada’s board chair. “This appointment not only highlights the importance of prioritizing dementia research, but also emphasizes the value of including experts like Dr. Pisterzi in discussions that shape the future of dementia care.”
 
Dr. Pisterzi’s appointment reflects a commitment to addressing the growing impact of Alzheimer’s disease and other forms of dementia in Canada. By 2030, more than 1 million people are expected to be living with dementia in Canada; the need for research and policy solutions is pressing.
 
Dr. Pisterzi’s role on the board will help guide efforts to improve outcomes for individuals living with dementia and their families, ensuring that their voices are heard and their needs are met.